op-ed | Guinea pigs: Editorial on the excessive use of Indians in global clinical trials

India has emerged as a favoured pharmaceutical hub owing to such factors as a population with a large genetic pool, a streamlined approval process, high disease burdens, and low operational costs

Related Keywords

India ,Russia ,Cape Town ,Western Cape ,South Africa ,Brazil , ,Cape Town Statement ,Clinical Trials Registry ,Op Ed ,He Editorial Board ,Clinical Trials ,Medicine ,